IDL Diagnostics AB Sustainability Reports
IDL Diagnostics AB develops, manufactures, and markets blood and urine-based in vitro diagnostic tests worldwide. The company specializes in oncology and bacteriology markers to monitor diseases like urological cancers and typhoid fever.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300RF3VQBLGOJ7J46
FIGI: BBG001V0XL09
1 reports from 2025 to 2025
